Determining the acceptability of a novel One Health vaccine for Rift Valley Fever prior to phase II/III clinical trials in Uganda

Several vaccine candidates for Rift Valley Fever (RVF) are in development for use in humans. A promising candidate, ChAdOx1 RVF vaccine, has been developed for use in both humans and animals, and has undergone field trials in livestock in Kenya. We conducted a qualitative study to explore the accept...

Descripción completa

Detalles Bibliográficos
Autores principales: Bowmer, Alexander, Ssembatya, Joseph, Okot, Mark, Bagyenyi, Richard, Rubanga, Stephen Venny, Kalema-Zikusoka, Gladys
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747655/
https://www.ncbi.nlm.nih.gov/pubmed/36531661
http://dx.doi.org/10.1016/j.onehlt.2022.100470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747655/
https://www.ncbi.nlm.nih.gov/pubmed/36531661
http://dx.doi.org/10.1016/j.onehlt.2022.100470

Ejemplares similares